The study also revealed the suppressed expression of β-amyloid and tau protein, which is a well-known pivotal protein in the pathogenesis of Alzheimer’s disease in patients with Alzheimer’s disease after treatment with tetracycline [23,24,25]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.